Biden Opioid Plan Puts Pharmacies On Notice

November 08, 2020

White Collar Defense and Investigations Group Chair and Partner Jodi Avergun shares her insights on how President-elect Joe Biden’s administration is anticipated to expand the focus of federal opioid investigations, litigation and the next wave of enforcement actions amid the decades-long national opioid crisis.

Read the article.

CadwaladerNews

CadwaladerSpotlight

Making a Mark on Our Communities: Pro Bono Report 2020

Cadwalader's research and intelligence platform provides analysis on changes in U.S. financial regulation. Subscribers receive a daily newsletter interpreting new laws, rules and enforcement actions that impact financial institutions.